ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 237 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $184 | -15.6% | 8,884 | -23.6% | 0.00% | 0.0% |
| Q1 2023 | $218 | -99.8% | 11,628 | +158.5% | 0.00% | – |
| Q2 2021 | $110,000 | -44.7% | 4,499 | -41.7% | 0.00% | -100.0% |
| Q1 2021 | $199,000 | +22.8% | 7,711 | +154.7% | 0.00% | 0.0% |
| Q4 2020 | $162,000 | +362.9% | 3,028 | +257.1% | 0.00% | – |
| Q3 2020 | $35,000 | -27.1% | 848 | -13.9% | 0.00% | – |
| Q2 2020 | $48,000 | – | 985 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |